David Palling
16Patents
4h-index
14Co-inventors
53Inventor score
Filing activity: May 23, 2007 → May 31, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10857133B2 | Secnidazole for use in the treatment of bacterial vaginosis | Chemistry; Metallurgy | 7 | Active |
| US10849884B2 | Secnidazole for use in the treatment of bacterial vaginosis | Chemistry; Metallurgy | 7 | Active |
| US10682338B2 | Secnidazole for use in the treatment of bacterial vaginosis | Chemistry; Metallurgy | 6 | Active |
| US7501439B2 | Tartrate salt of isofagomine and methods of use | Human Necessities | 6 | Active |
| US9458118B2 | Sodium channel modulators for the treatment of pain and diabetes | Chemistry; Metallurgy | 2 | Active |
| US10335390B2 | Secnidazole for use in the treatment of bacterial vaginosis | Chemistry; Metallurgy | 2 | Active |
| US11000507B2 | Secnidazole for use in the treatment of bacterial vaginosis | Chemistry; Metallurgy | 1 | Active |
| US11020377B2 | Secnidazole for use in the treatment of bacterial vaginosis | Chemistry; Metallurgy | 1 | Active |
| US11000508B2 | Secnidazole for use in the treatment of trichomoniasis | Chemistry; Metallurgy | 1 | Active |
| US11602522B2 | Secnidazole for use in the treatment of sexually transmitted infection | Chemistry; Metallurgy | 0 | Active |
| US7863453B2 | Tartrate salt of isofagomine and methods of use | Human Necessities | 0 | Active |
| US10179781B2 | Sodium channel modulators for the treatment of pain | Chemistry; Metallurgy | 0 | Active |
| US12280037B2 | Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof | Human Necessities | 0 | Active |
| US11324721B2 | Secnidazole for use in the treatment of trichomoniasis | Chemistry; Metallurgy | 0 | Active |
| US11253501B2 | Secnidazole formulations and use in treating bacterial vaginosis | Human Necessities | 0 | Active |
| US11684607B2 | Secnidazole for use in the treatment of bacterial vaginosis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.